Press-release for stocks related to fda for ABMD

Prices are updated after-hours

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
Published: 2022-12-21 (Crawled : 14:20) - biospace.com/
ABMD | $381.02 0.06% 0.07%

| 0.06% | O: -0.0% H: 0.13% C: 0.06%
fda heart trial

Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

| 47.65% | O: -0.81% H: 0.0% C: 0.0%
fda heart approval

U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath
Published: 2022-10-17 (Crawled : 14:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

| 52.85% | O: 2.59% H: 1.19% C: 0.83%
fda clearance grants

FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)
Published: 2022-09-16 (Crawled : 13:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

| 44.48% | O: -0.92% H: 0.0% C: -1.01%
fda trial

FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump
Published: 2021-08-18 (Crawled : 13:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

| 15.97% | O: 0.06% H: 2.32% C: 0.62%
fda heart device granted grant designation

FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure
Published: 2021-06-29 (Crawled : 13:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%

| 21.95% | O: -0.36% H: 1.48% C: 0.63%
fda heart approval granted grant

66%

34%

CZOO | $11.44 129.26% 4.6M

AMST | $3.4 70.0% 51M

BOF | $1.78 52.14% 15M

CSSE 4 | $0.23 51.02% 46M

TROO | $1.57 44.04% 2.8M

RILY | $30.87 42.13% 7.8M

LICN | $0.76 35.71% 6.2M

MULN | News | $3.53 29.3% 4.8M

RBBN 4 | $3.26 26.85% 1.2M

RCAT | $1.52 26.67% 1.3M

Save your searches and get alerts when important news are released.